Advancing South Asian Cardiovascular Health
An In-Person & Virtual International CE accredited Conference Focusing on South Asian Heart Health
The international conference brought together the voices of world-renowned experts in the field as well as patients and community members who live with heart disease in an efort to understand how collaborative decision-making can help improve heart health outcomes in South Asians in the United States. South Asians are among the fastest growing ethnic groups in the US, and show high rates of heart disease, as compared to other populations.
South Asians (SA) are among the fastest growing racial/ethnic groups in the US and bear a highly disproportionate burden of cardiovascular disease (CVD). SAs have the highest CVD rates among all racial/ethnic groups in the US, with a significantly higher prevalence of coronary artery disease (CAD), type 2 diabetes, hypertension, and a higher percentage of body fat than other immigrant groups and whites. Also, SAs tend to develop CAD at a younger age, often before 40 in men, and are more likely to die from CAD than other ethnic groups.
SAs in the US have few established resources related to their high risk for CVD, with significant implications for their health and well-being. Poor CVD outcomes management in SAs may be due to a lack of culturally and linguistically appropriate education materials for patients, inadequate patient knowledge of the healthcare system, lack of health insurance, and other social determinants – an area of further research. This diverse population also often faces tremendous cultural, socioeconomic, linguistic, and structural obstacles to achieving good health. Compounding these challenges, there is a dearth of detailed data on the unique risks, etiologic mechanisms, and effective interventions for CVD in first- and second-generation SAs in the US. This can lead to sub-optimal management of CVD, its risk factor modification, and thus increased recurrent CAD events, exacerbating racial/ethnic disparities and increasing the economic burden of CVD in the US.
In order to begin reversing this knowledge deficit, providers, patients, and shareholders need to be able to 1) identify risk factors, including social determinants, 2) learn about CVD management from worldwide programs, 3) understand the value of research participation in establishing priorities for future work on managing CVD in SAs in the US.
This international conference on South Asian cardiovascular health was designed to provide a high-quality scientific forum in a collaborative environment, which included patients and providers. Internationally renowned researchers and clinicians lead sessions addressing
CVD risk factors, barriers to management, the role of Big Data, community prevention strategies, and the state of South Asian cardiovascular health in the United States from the AHA, ADA, and NIH perspectives.
Goals & Objectives
- Improve identification of risk factors, including social determinants, of cardiovascular disease in South Asians to create a framework for strategies for prevention, early diagnosis, and targeted treatment
- Exchange information from worldwide programs to understand and enhance cardiovascular disease management and post-acute care in South Asians
- Establish a list of priorities for future work on managing cardiovascular disease in South Asians
In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences, SKN Foundation, Eastern Virginia Medical School and Saint Peter’s University Hospital. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 10.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This activity is awarded 10.25 ANCC contact hours. Nurses should claim only those contact hours actually spent participating in the activity.
Physician Assistants: NCCPA accepts certificates of participation for educational activities approved for AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
Method of Participation
Salim Yusuf, D.Phil, FRCPC, FRSC, O.C
Heart and Stroke Foundation/Marion W. Burke Chair in Cardiovascular Disease
Distinguished University Professor of Medicine, McMaster University, Ontario, Canada
Raj Bhopal, CBE, DSc (hon), MD, BSc, MBChB, MPH, FRCP(E), FFPH
Emeritus Professor of Public Health Edinburgh Migration, Ethnicity and Health Research Group, Usher Institute, Medical School, University of Edinburgh
SPECIAL GUEST SPEAKERS
MD, CDCES, FACE, MACP
President, Medicine & Science, American Diabetes Association
Professor of Medicine, Emory University School of Medicine;
Division of Endocrinology, Metabolism,
Chief of Diabetes and Endocrinology, Grady Health Systems,
Emory University School of Medicine, GA
MD, ScM, FACC, FAHA
President, American Heart Association
Chair, Department of Preventive Medicine.
Eileen M. Foell Professor. Professor of Preventive Medicine
(Epidemiology), Medicine (Cardiology) and Pediatrics,
Northwestern University Feinberg School of Medicine, IL
MS, PhD, FACC, FAHA
Professor of Medicine and Global Health, University of Toronto
Professor and Advisor to the Dean on Global Health, Faculty of Health, York University, Toronto, Canada
Founding Director, Office of Global Health, NHLBI, NIH
MD, MSc, PhD, FAHA
Chief, Epidemiology Branch
Division of Cardiovascular Sciences
Professor of Medicine, Epidemiology and Biostatistics, Division of General Internal Medicine, University of California, San Francisco (UCSF), CA
Co-Leader, Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study
Co- Founder & Executive Director, South Asian Heart Center, El Camino Hospital, Mountain View, CA
MD, FRCP (London, Edinburgh, Glasgow & Ireland), PhD, DSc, D.c (Hon. Causa), FNASc, FASc, FNA, FACE, FACP, FTWAS, MACP, FRS (Edinburgh)
Chairman, Dr. Mohan’s Diabetes Specialities Centre of Excellence in Diabetes Care, Southern India President and Director, Madras Diabetes Research Foundation, Chennai, India
Professor of Medicine (Primary Care and Population Health), Stanford University School of Medicine, CA
Scientific Director, Precision Genomics and Pharmacogenomics in Primary Care, Stanford Division of Primary Care and Population Health
Faculty Co-Director, Stanford Biobank
Co-Founder and Co-Director, Center for Asian Health Research and Education (CARE), Stanford Medicine
Daniel J. Rader
Chief, Division of Translational Medicine and Human Genetics
Associate Director, Institute for Translational Medicine and Therapeutics
Director, Preventive Cardiovascular Program
Seymour Gray Professor of Molecular Medicine, Perelman School of Medicine, University of Pennsylvania, PA
MD, PhD, FACC, FAHA, FASPC
Professor in Cardiology and Cardiovascular Research
Director, Cardiovascular Disease Fellowship Training Program, Baylor College of Medicine, Houston, TX
Co-Director, VA Advanced Fellowship Program in Health Services Research & Development
CONFERENCE LEADERSHIP TEAM
Sunita Dodani MBBS (MD), FCPS, MSc, PhD, FAHA
Professor of Medicine, Department of Internal Medicine & Professor, School of Health Professions (SHP)
Eastern Virginia Medical School (EVMS), & Founding Director, EVMS-Sentara Healthcare Analytics and Delivery Science Institute (HADSI)
Founder and Chair, Health Equity Collaborative of Virginia
Board Member, American Heart Association- National Research Committee
Board Director, American Heart Association- Hampton Roads Chapter
Naveen Mehrotra, MD, MPH
Director, My Whole Child Pediatrics
Founder and Executive Director, SKN Foundation
Clinical Assistant Professor of Pediatrics, Rutgers-RWJ Medical School
Adjunct Assistant Professor, Rutgers-RWJ School of Public Health
Meena S. Murthy, MD, FACE
Chief, Division of Endocrinology, Nutrition and Metabolism
Director, Thyroid and Diabetes Center
Director, South Asian Institute and SKN South Asian Diabetes Center
Saint Peter’s University Hospital, New Brunswick, NJ
About the Medical Society of New Jersey:
Founded in 1766, the Medical Society of New Jersey (MSNJ) is the oldest professional society in the United States. MSNJ has a mission to promote the betterment of the public health and the science and the art of medicine, to enlighten public opinion in regard to the problems of medicine, and to safeguard the rights of the practitioners of medicine. MSNJ represents all medical disciplines and serves as an advocate for patient and physician rights. Its members are dedicated to ensuring delivery of the highest quality medical care throughout New Jersey. For more information, visit www.msnj.org.